MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$14,969K
Interest income
$2,505K
Net loss
-$14,456K
Unrealized loss (gain) on
marketable securities
-$513K
Total other income,
net
$2,448K
Other expense, net
-$57K
Loss from operations
-$16,904K
Total operating
expenses
$16,904K
Research and development
$11,648K
General and
administrative
$5,256K
Back